1. Home
  2. NMG vs OCGN Comparison

NMG vs OCGN Comparison

Compare NMG & OCGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NMG
  • OCGN
  • Stock Information
  • Founded
  • NMG 2011
  • OCGN 2013
  • Country
  • NMG Canada
  • OCGN United States
  • Employees
  • NMG N/A
  • OCGN N/A
  • Industry
  • NMG Other Metals and Minerals
  • OCGN Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • NMG Basic Materials
  • OCGN Health Care
  • Exchange
  • NMG Nasdaq
  • OCGN Nasdaq
  • Market Cap
  • NMG 249.7M
  • OCGN 283.3M
  • IPO Year
  • NMG 2017
  • OCGN N/A
  • Fundamental
  • Price
  • NMG $1.94
  • OCGN $1.00
  • Analyst Decision
  • NMG Strong Buy
  • OCGN Strong Buy
  • Analyst Count
  • NMG 2
  • OCGN 3
  • Target Price
  • NMG $2.58
  • OCGN $6.00
  • AVG Volume (30 Days)
  • NMG 185.0K
  • OCGN 3.0M
  • Earning Date
  • NMG 08-18-2025
  • OCGN 08-01-2025
  • Dividend Yield
  • NMG N/A
  • OCGN N/A
  • EPS Growth
  • NMG N/A
  • OCGN N/A
  • EPS
  • NMG N/A
  • OCGN N/A
  • Revenue
  • NMG N/A
  • OCGN $4,754,000.00
  • Revenue This Year
  • NMG N/A
  • OCGN N/A
  • Revenue Next Year
  • NMG N/A
  • OCGN N/A
  • P/E Ratio
  • NMG N/A
  • OCGN N/A
  • Revenue Growth
  • NMG N/A
  • OCGN N/A
  • 52 Week Low
  • NMG $1.22
  • OCGN $0.52
  • 52 Week High
  • NMG $2.58
  • OCGN $1.40
  • Technical
  • Relative Strength Index (RSI)
  • NMG 53.58
  • OCGN 47.32
  • Support Level
  • NMG $1.89
  • OCGN $0.93
  • Resistance Level
  • NMG $2.00
  • OCGN $1.11
  • Average True Range (ATR)
  • NMG 0.11
  • OCGN 0.06
  • MACD
  • NMG -0.01
  • OCGN -0.01
  • Stochastic Oscillator
  • NMG 40.20
  • OCGN 27.07

About NMG Nouveau Monde Graphite Inc.

Nouveau Monde Graphite Inc is a mineral exploration company. The company specializes in the exploration, evaluation, and development of mineral properties located in Quebec and is developing a natural graphite-based anode material that would qualify as battery-grade material to supply the lithium-ion industry. The company currently operates in two segments: the Matawinie Mine Project and the Battery Material Plant project.

About OCGN Ocugen Inc.

Ocugen Inc company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines that improve health and offer hope for patients across the globe. The company's pipeline includes Modifier Gene Therapy Platform, Novel Biologic Therapy for Retinal Diseases, Regenerative Medicine Cell Therapy Platform, Inhaled Mucosal Vaccine Platform. The company is developing a modifier gene therapy platform designed to fulfill unmet medical needs related to retinal diseases, including inherited retinal diseases ("IRDs"), such as RP, LCA, Stargardt disease, and multifactorial diseases such as dAMD and Geographic Atrophy ("GA").

Share on Social Networks: